Cryosurgery for Bone Tumors

Cryosurgery for tumors in Israel is a cutting-edge technique that uses extreme cold to destroy pathological tissue. It is indicated for both benign and malignant bone tumors, including Ewing’s sarcoma, and is also used in some bone-like disorders such as Paget’s disease. The tumors are typically located in the limbs, pelvis, spine, or shoulder girdle and may be primary or metastatic.

This cryosurgery cancer treatment abroad is particularly beneficial for patients seeking a less invasive, tissue-preserving procedure that does not involve radiation.

Less than a decade ago, Israeli specialists developed a unique closed cryogenic system that uses helium and argon to freeze tissues at temperatures between -60°C and -180°C. This method allows for cryosurgery for tumors without waiting, even in hard-to-reach locations like the spine or pelvic bones, areas that were previously inaccessible with traditional open cryotherapy.

Thanks to this innovation, no wait cryosurgery for tumors is now possible for international patients as well, offering timely intervention and reduced risks.

During cryosurgery for bone tumors, the tumor is accessed through a small incision and removed using specialized surgical tools. The tumor bed and surrounding tissue are then frozen using the helium-argon system. The resulting cavity is reconstructed using bone cement or implants to restore structural stability.

The procedure is performed under general anesthesia and typically lasts 1–2 hours. It is a highly targeted form of cryosurgery that minimizes joint damage and often prevents the need for amputation.

• Preservation of the bone and joint
• Reduced risk of local recurrence
• Avoidance of side effects typical for radiation therapy (nausea, fatigue, hair loss)
• Shorter recovery times
• Highly suitable for no wait cryosurgery for bone tumors in cases where timing is critical

Clinical studies have shown that cryosurgery for bone tumors without waiting offers outcomes comparable to radiotherapy, but with fewer adverse effects and improved quality of life.

After surgery, the patient is observed in a recovery unit and then transferred to a standard ward. Discharge occurs within a few days, and patients are advised to watch for any signs of fever or infection. Follow-up includes physical rehabilitation and imaging to ensure the tumor has not recurred.